Cargando…
Amlamax™ in the Management of Dyslipidemia in Humans
Hypercholesterolemia is the major cause of cardiovascular diseases leading to myocardial infarctions leading to considerable morbidity and mortality. During the past decade a group of molecules referred to as statins such as simvastatin, atrovastatin have been tried with great success in reducing to...
Autores principales: | Antony, B., Merina, B., Sheeba, V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792547/ https://www.ncbi.nlm.nih.gov/pubmed/20046781 http://dx.doi.org/10.4103/0250-474X.44604 |
Ejemplares similares
-
Cross-sectional Study Shows an Association between Paediatric Lichen Planus and Dyslipidemia
por: Mahajan, Rahul, et al.
Publicado: (2022) -
The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome
por: Akbarzadeh, Marzieh, et al.
Publicado: (2019) -
Secondary Dyslipidemia In Obese Children - Is There Evidence For
Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018) -
High Prevalence of Dyslipidemia in Children and Adolescents: Opportunity for Prevention
por: Mangili, Leonardo
Publicado: (2020) -
Oral lesions in human monkeypox disease and their management
por: Joseph, Betsy, et al.
Publicado: (2023)